Evidence map›Paper›PMID 15098003›Full record

ArticleMolecular psychiatry2004

Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress.

S Prabakaran, J E Swatton, M M Ryan, S J Huffaker, J T-J Huang, J L Griffin, M Wayland, T Freeman, F Dudbridge, K S Lilley and 8 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03788759 (Alpha-lipoic Acid Adjunctive Therapy in Schizophrenia), which is not on this map. Cited by 481 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
481citing papers in PubMed, 8 pooled it
15.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03788759 phase2 / phase3completednot on this mapstarted 2019, after this paper: background citation

Alpha-lipoic Acid Adjunctive Therapy in Schizophrenia: A Randomized, Double-blind, Placebo-controlled Trial

TypeinterventionalSponsorNucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do CearaRan2019 to 2021Enrolled48ConditionsSchizophrenia, Oxidative StressArmsAlpha-lipoic acid, Placebo Oral Tablet
3 · Its place in the literature

Who cites it

481 citing papers in PubMed, 8 syntheses or guidelines pooled it, 966 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

421 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 2 countries.

S PrabakaranDepartment of Neurobiology, Babraham Institute, Cambridge, UK.
J E Swatton
M M Ryan
S J Huffaker
J T-J Huang
J L Griffin
M Wayland
T Freeman
F Dudbridge
K S Lilley
N A Karp
S Hester
D Tkachev
M L Mimmack
R H Yolken
M J Webster
E F Torrey
S Bahn
University of Cambridge · GBBabraham Institute · GBMRC Human Nutrition Research · GBAddenbrooke's Hospital · GBUniformed Services University of the Health Sciences · USJohns Hopkins University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The etiology and pathophysiology of schizophrenia remain unknown. A parallel transcriptomics, proteomics and metabolomics approach was employed on human brain tissue to explore the molecular disease signatures. Almost half the altered proteins identified by proteomics were associated with mitochondrial function and oxidative stress responses. This was mirrored by transcriptional and metabolite perturbations. Cluster analysis of transcriptional alterations showed that genes related to energy metabolism and oxidative stress differentiated almost 90% of schizophrenia patients from controls, while confounding drug effects could be ruled out. We propose that oxidative stress and the ensuing cellular adaptations are linked to the schizophrenia disease process and hope that this new disease concept may advance the approach to treatment, diagnosis and disease prevention of schizophrenia and related syndromes.

Indexed as

BrainFatty AcidsGenome, HumanGlucoseHumansHypoxia, BrainMitochondrial DiseasesOligonucleotide Array Sequence AnalysisOxidative PhosphorylationOxidative StressProteomicsSchizophreniaSignal TransductionFatty AcidsGlucose

Identifiers

PMID15098003
OpenAlexW2075650547

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.